Baptist Heart-Cardiology, Mississippi Baptist Medical Center, Jackson, MS, USA.
Franchise Health Economics & Market Access, Johnson & Johnson, Irvine, CA, USA.
J Comp Eff Res. 2022 Jun;11(9):659-668. doi: 10.2217/cer-2021-0170. Epub 2022 May 10.
To compare cost and readmissions among atrial fibrillation (AF) patients undergoing ablation using the THERMOCOOL SMARTTOUCH™ SF (STSF) radiofrequency catheter versus the Arctic Front Advance™ (AFA) cryoballoon catheter. The Premier Healthcare Database was used for the study purposes. Propensity score matching was used to match patients in the two groups. Costs and readmissions were assessed. A regression model was used for outcome assessment. After propensity matching, 2767 patients were identified in each of the STSF and AFA cohorts. In the matched cohort, STSF patients had significantly lower supply costs than AFA patients. STSF patients had significantly lower 4-12-month AF-related inpatient readmissions compared with AFA patients (2.58% vs 3.99%; p = 0.0402). Costs of care summing index procedure and readmission costs were also lower for the STSF patients versus AFA patients. Patients who underwent AF ablation using the STSF catheter versus the AFA catheter had lower cost and AF-related readmissions.
比较使用 THERMOCOOL SMARTTOUCH™ SF（STSF）射频导管和 Arctic Front Advance™（AFA）冷冻球囊导管进行消融术的心房颤动（AF）患者的成本和再入院率。研究目的是使用 Premier Healthcare Database。使用倾向评分匹配将两组患者进行匹配。评估成本和再入院率。在倾向评分匹配后，在 STSF 和 AFA 队列中各确定了 2767 例患者。在匹配队列中，STSF 患者的供应成本明显低于 AFA 患者。与 AFA 患者相比，STSF 患者的 4-12 个月 AF 相关住院再入院率显著降低（2.58%对 3.99%；p=0.0402）。STSF 患者的护理费用总和指数程序和再入院费用也低于 AFA 患者。与使用 AFA 导管进行 AF 消融术的患者相比，使用 STSF 导管的患者的成本和 AF 相关再入院率更低。
